Home/Filings/4/0001177648-21-000019
4//SEC Filing

Vance Terry 4

Accession 0001177648-21-000019

CIK 0001177648other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:45 PM ET

Size

5.3 KB

Accession

0001177648-21-000019

Insider Transaction Report

Form 4
Period: 2021-03-02
Vance Terry
Director
Transactions
  • Award

    Stock Option (right to buy)

    2021-03-02+7,5007,500 total
    Exercise: $49.92Exp: 2031-03-02Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 2, 2021), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2022 annual meeting of stockholders.

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeother

Related Parties

1
  • filerCIK 0001572282

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:45 PM ET
Size
5.3 KB